Ceragon Networks Ltd
NASDAQ:CRNT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ceragon Networks Ltd
NASDAQ:CRNT
|
IL |
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
S
|
Sbc Corporation Bhd
KLSE:SBCCORP
|
MY |
|
Z
|
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
|
CN |
|
Emerson Electric Co
NYSE:EMR
|
US |
|
Ab Dynamics PLC
LSE:ABDP
|
UK |
|
H
|
HEICO Corp
NYSE:HEI.A
|
US |
Balance Sheet
Balance Sheet Decomposition
Ceragon Networks Ltd
Ceragon Networks Ltd
Balance Sheet
Ceragon Networks Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
6
|
5
|
7
|
11
|
10
|
10
|
59
|
28
|
38
|
38
|
29
|
47
|
42
|
41
|
36
|
36
|
26
|
36
|
24
|
27
|
17
|
23
|
28
|
35
|
|
| Cash Equivalents |
6
|
5
|
7
|
11
|
10
|
10
|
59
|
28
|
38
|
38
|
29
|
47
|
42
|
41
|
36
|
36
|
26
|
36
|
24
|
27
|
17
|
23
|
28
|
35
|
|
| Short-Term Investments |
47
|
23
|
15
|
15
|
10
|
12
|
32
|
37
|
47
|
31
|
17
|
0
|
6
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5
|
6
|
8
|
11
|
20
|
33
|
47
|
75
|
71
|
92
|
161
|
168
|
150
|
177
|
129
|
120
|
126
|
132
|
125
|
114
|
118
|
109
|
114
|
161
|
|
| Accounts Receivables |
3
|
4
|
5
|
7
|
15
|
27
|
41
|
71
|
69
|
88
|
143
|
149
|
131
|
163
|
117
|
107
|
114
|
124
|
119
|
107
|
108
|
100
|
104
|
150
|
|
| Other Receivables |
2
|
1
|
3
|
5
|
5
|
6
|
7
|
4
|
2
|
4
|
18
|
19
|
19
|
15
|
12
|
12
|
12
|
8
|
7
|
7
|
10
|
9
|
10
|
11
|
|
| Inventory |
7
|
8
|
11
|
19
|
16
|
27
|
37
|
41
|
66
|
66
|
94
|
66
|
64
|
62
|
50
|
46
|
54
|
54
|
62
|
51
|
61
|
72
|
69
|
60
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
4
|
10
|
9
|
16
|
28
|
28
|
23
|
12
|
12
|
5
|
5
|
4
|
4
|
8
|
7
|
7
|
7
|
5
|
|
| Total Current Assets |
65
|
41
|
42
|
57
|
56
|
84
|
179
|
191
|
231
|
242
|
328
|
310
|
285
|
293
|
227
|
207
|
211
|
225
|
216
|
200
|
204
|
211
|
218
|
261
|
|
| PP&E Net |
5
|
4
|
3
|
3
|
3
|
3
|
4
|
9
|
12
|
16
|
31
|
34
|
35
|
33
|
29
|
28
|
30
|
34
|
35
|
39
|
50
|
47
|
49
|
53
|
|
| PP&E Gross |
5
|
4
|
3
|
3
|
3
|
3
|
4
|
9
|
12
|
16
|
31
|
34
|
35
|
33
|
29
|
28
|
30
|
34
|
35
|
39
|
50
|
47
|
49
|
53
|
|
| Accumulated Depreciation |
3
|
5
|
6
|
7
|
8
|
9
|
10
|
12
|
15
|
20
|
54
|
64
|
45
|
53
|
61
|
67
|
74
|
81
|
90
|
97
|
108
|
118
|
132
|
141
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
10
|
7
|
5
|
3
|
2
|
2
|
7
|
8
|
6
|
6
|
8
|
16
|
17
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
15
|
15
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
0
|
0
|
0
|
11
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
16
|
16
|
12
|
13
|
7
|
31
|
32
|
13
|
13
|
4
|
4
|
4
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
2
|
2
|
3
|
3
|
12
|
14
|
15
|
21
|
21
|
19
|
10
|
7
|
6
|
6
|
17
|
32
|
28
|
23
|
23
|
7
|
6
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
15
|
15
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
|
| Total Assets |
72
N/A
|
62
-15%
|
62
+1%
|
73
+17%
|
74
+1%
|
96
+30%
|
218
+126%
|
244
+12%
|
269
+10%
|
287
+7%
|
411
+43%
|
394
-4%
|
366
-7%
|
342
-7%
|
267
-22%
|
244
-9%
|
254
+4%
|
283
+12%
|
290
+2%
|
272
-6%
|
293
+7%
|
289
-1%
|
299
+3%
|
345
+16%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
5
|
6
|
6
|
9
|
12
|
22
|
26
|
41
|
53
|
41
|
80
|
102
|
78
|
102
|
74
|
68
|
76
|
79
|
60
|
64
|
69
|
67
|
91
|
121
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
8
|
9
|
32
|
23
|
33
|
28
|
16
|
15
|
17
|
19
|
22
|
19
|
19
|
16
|
20
|
22
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
6
|
15
|
38
|
33
|
25
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
25
|
47
|
49
|
35
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
5
|
5
|
6
|
9
|
9
|
14
|
20
|
14
|
21
|
25
|
54
|
30
|
20
|
27
|
20
|
10
|
13
|
12
|
9
|
12
|
13
|
12
|
13
|
14
|
|
| Total Current Liabilities |
10
|
11
|
11
|
18
|
21
|
37
|
47
|
55
|
81
|
74
|
173
|
180
|
178
|
206
|
145
|
111
|
106
|
110
|
104
|
100
|
116
|
133
|
133
|
151
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
19
|
10
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
2
|
3
|
3
|
3
|
12
|
10
|
7
|
7
|
9
|
50
|
51
|
42
|
30
|
20
|
18
|
14
|
13
|
25
|
26
|
40
|
37
|
32
|
27
|
|
| Total Liabilities |
12
N/A
|
12
+8%
|
14
+10%
|
21
+53%
|
25
+19%
|
49
+97%
|
57
+16%
|
61
+8%
|
89
+44%
|
83
-6%
|
250
+201%
|
250
0%
|
231
-8%
|
237
+3%
|
164
-31%
|
128
-22%
|
120
-7%
|
123
+3%
|
130
+5%
|
126
-2%
|
155
+23%
|
170
+9%
|
165
-3%
|
179
+9%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
104
|
118
|
126
|
124
|
128
|
134
|
121
|
95
|
91
|
77
|
131
|
154
|
201
|
278
|
277
|
265
|
250
|
227
|
229
|
247
|
262
|
281
|
275
|
251
|
|
| Additional Paid In Capital |
169
|
169
|
175
|
177
|
177
|
181
|
281
|
285
|
292
|
301
|
312
|
318
|
358
|
406
|
408
|
409
|
411
|
415
|
418
|
421
|
428
|
432
|
437
|
447
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
|
| Other Equity |
5
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
9
|
8
|
7
|
9
|
9
|
8
|
10
|
11
|
8
|
10
|
|
| Total Equity |
61
N/A
|
49
-19%
|
49
-1%
|
52
+7%
|
49
-6%
|
48
-3%
|
161
+238%
|
183
+14%
|
181
-1%
|
204
+13%
|
161
-21%
|
144
-11%
|
135
-6%
|
105
-23%
|
103
-2%
|
116
+13%
|
134
+15%
|
160
+19%
|
160
+1%
|
146
-9%
|
137
-6%
|
120
-13%
|
134
+12%
|
166
+24%
|
|
| Total Liabilities & Equity |
72
N/A
|
62
-15%
|
62
+1%
|
73
+17%
|
74
+1%
|
96
+30%
|
218
+126%
|
244
+12%
|
269
+10%
|
287
+7%
|
411
+43%
|
394
-4%
|
366
-7%
|
342
-7%
|
267
-22%
|
244
-9%
|
254
+4%
|
283
+12%
|
290
+2%
|
272
-6%
|
293
+7%
|
289
-1%
|
299
+3%
|
345
+16%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
22
|
23
|
25
|
26
|
26
|
27
|
37
|
36
|
34
|
35
|
36
|
37
|
53
|
77
|
78
|
78
|
78
|
80
|
81
|
82
|
84
|
84
|
85
|
88
|
|